12 April 2017

HNL TRADE Co. -- Main Portfolio

Watchlist -- 13 April 2017

Trades

Pending Trades:

Limit Sell 172 shares of AA @ $35.14 (0%)

Limit Sell 392 shares of ACET @ $16.11 (5%)

Limit Sell 513 shares of CYTK @ $12.30 (5%)

Limit Sell 901 shares of MDR @ $7.00 (5%)

Limit Sell 306 shares of MGNX @ $19.60 (0%)

Limit Sell 316 shares of RES @ $19.96 (5%)

Limit Sell 323 shares of UA @ $19.54 (5%)

Limit Sell 111 shares of USB @ $54.19 (5%)

Purchases:

N/A

Sells:

Sold 1666 shares of AUO @ $4.13 for a 5% gain

Thoughts:

Busted on big prediction Tuesday, ah well...we can't win them all. Unloaded AUO this morning for a 5% gain. Looking very seriously @ OMED tomorrow morning. Happy Trading!

AA - Systematic investing. 5% and out.

ACET - Systematic investing. 5% and out.

CYTK - Systematic Investing. 5% and out.

DRYS - NOT RECOMMENDED. We've covered DRYS for nearly a year now and we've always aimed @ a $1.20 entry point. This company could go bankrupt tomorrow or it could be trading @ $40 in 2020; neither would surprise us. Wait and wish.

MDR - Systematic investing. 5% and out.

MGNX - Systematic investing. 5% and out.

RES - Systematic investing. 5% and out.

UA - Systematic investing. 5% and out.

USB - Systematic Investing. 5% and out.

ACOR - Great potential -- just beginning coverage. Hopefully will remain stagnant for a few days for monitoring and us to develop some free capital.

AUO - Monitoring. Desired re-entry of $4.00.

CNQ - Monitoring -- We probably missed the easy money on this. Will continue to monitor for a week or so, but it's probably already gone.

CPG - Monitoring -- We probably missed the easy money on this. Will continue to monitor for a week or so, but it's probably already gone.

FOMX - There's some risk with this stock, but a lot of upside. Would like to see this trade down over the next week or so (with some luck), if the price is stable or cheaper, it becomes an excellent buy.

GLYC - We've been searching for a pharmaceutical with big gain potential and this could be it.

OMED - Monitoring -- Not Recommended

SHOP - This stock is out of sight right now...unfortunately. We have a history, so we'll keep an eye on it. Looks very overbought.

SSW - The whole shipping industry is suffering as a whole right now, but when, not if, it recovers Seaspan will once again lead the pack. Still a little risky at the moment. Monitoring.

UPS - Safe. Slow. Reasonable amount of upside for a $100 stock. 

VSTM - Sold @ $1.39. Desired re-entry @ $1.30. Target Price $2.50

James PauleyComment